We are live on ! Find out more
MC

Middleton & Co Portfolio holdings

AUM $877M
1-Year Est. Return 15.2%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+15.2%
3 Year Est. Return
+63.4%
5 Year Est. Return
+82.2%
10 Year Est. Return
+352.6%
AUM
$456M
AUM Growth
+$13M
Cap. Flow
-$15.4M
Cap. Flow %
-3.38%
Top 10 Hldgs %
27.45%
Holding
159
New
4
Increased
30
Reduced
95
Closed
6

Top Sells

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$2.47M
2
BIIB icon
Biogen
BIIB
+$1.77M
3
CVS icon
CVS Health
CVS
+$1.71M
4
FL
Foot Locker
FL
+$1.66M
5
CTSH icon
Cognizant
CTSH
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 17.12%
2 Financials 15.58%
3 Technology 14.21%
4 Consumer Discretionary 12.24%
5 Communication Services 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
$6.51M 1.43%
78,362
-13,179
-14% -$1.11M
VZ icon
27
Verizon
VZ
$195B
$6.31M 1.38%
129,403
+7,033
+6% +$353K
CL icon
28
Colgate-Palmolive
CL
$73.1B
$5.7M 1.25%
77,854
-3,278
-4% -$229K
BRK.B icon
29
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.68M 1.25%
34,068
+2,941
+9% +$492K
BR icon
30
Broadridge
BR
$17.8B
$5.64M 1.24%
83,065
-739
-0.9% -$50.1K
SNI
31
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$5.37M 1.18%
68,487
-10,364
-13% -$801K
ORLY icon
32
O'Reilly Automotive
ORLY
$72.9B
$5.24M 1.15%
291,000
-19,470
-6% -$352K
ESRX
33
DELISTED
Express Scripts Holding Company
ESRX
$5.2M 1.14%
78,896
-7,225
-8% -$497K
STE icon
34
Steris
STE
$22.3B
$5.01M 1.1%
72,172
-1,486
-2% -$103K
CVS icon
35
CVS Health
CVS
$133B
$4.91M 1.08%
62,566
-21,432
-26% -$1.71M
SBUX icon
36
Starbucks
SBUX
$120B
$4.87M 1.07%
83,338
+20,548
+33% +$1.16M
HD icon
37
Home Depot
HD
$331B
$4.69M 1.03%
31,965
-2,990
-9% -$424K
USB icon
38
US Bancorp
USB
$98.2B
$4.66M 1.02%
90,442
+21,480
+31% +$1.15M
ROP icon
39
Roper Technologies
ROP
$38.8B
$4.56M 1%
22,087
-713
-3% -$143K
CDK
40
DELISTED
CDK Global, Inc.
CDK
$4.4M 0.97%
67,746
+51,179
+309% +$3.28M
CVX icon
41
Chevron
CVX
$392B
$4.19M 0.92%
39,053
+2,795
+8% +$314K
IJR icon
42
iShares Core S&P Small-Cap ETF
IJR
$109B
$4.06M 0.89%
58,654
-35,766
-38% -$2.47M
EL icon
43
Estee Lauder
EL
$30.4B
$3.93M 0.86%
46,350
-1,060
-2% -$87.6K
SYK icon
44
Stryker
SYK
$125B
$3.68M 0.81%
27,950
-1,232
-4% -$156K
IVV icon
45
iShares Core S&P 500 ETF
IVV
$878B
$3.6M 0.79%
15,160
+13,295
+713% +$3.11M
QCOM icon
46
Qualcomm
QCOM
$155B
$3.56M 0.78%
62,151
+14,330
+30% +$831K
JNJ icon
47
Johnson & Johnson
JNJ
$618B
$3.53M 0.77%
28,307
-915
-3% -$109K
BLK icon
48
Blackrock
BLK
$169B
$3.52M 0.77%
9,178
+1,394
+18% +$533K
IJH icon
49
iShares Core S&P Mid-Cap ETF
IJH
$122B
$3.43M 0.75%
100,255
+18,055
+22% +$614K
MCK icon
50
McKesson
MCK
$100B
$3.42M 0.75%
23,055
-1,913
-8% -$280K

Similar funds

Middleton & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Middleton & Co held 159 positions worth $456M, up 2.9% from $443M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Middleton & Co withdrew a net $15.4M in Q1 2017, closing 6 positions and reducing 95 holdings. Its most notable exit was Biogen, an estimated $1.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Middleton & Co opened a new position in J.M. Smucker worth $553K.

  • Middleton & Co's largest Q1 2017 buy was J.M. Smucker: 4,220 shares worth $553K.
  • Middleton & Co added most to CDK Global, Inc. in Q1 2017, an estimated $3.28M increase.
  • Middleton & Co's biggest Q1 2017 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $2.47M.
  • Middleton & Co fully exited Biogen in Q1 2017, selling an estimated $1.77M.
  • Middleton & Co's ten largest holdings make up 27% of its $456M portfolio in Q1 2017.
  • Middleton & Co opened 4 new positions and closed 6 in Q1 2017.
  • Middleton & Co's portfolio value rose 2.9% quarter-over-quarter to $456M.

Based on Middleton & Co's 13F filing for Q1 2017, filed 19 Apr 2017.